Skip to main content
padlock icon - secure page this page is secure

Highly variable clinical phenotype of carbamylphosphate synthetase 1 deficiency in one family: an effect of allelic variation in gene expression?

Buy Article:

$59.00 + tax (Refund Policy)

Klaus V, Vermeulen T, Minassian B, Israelian N, Engel K, Lund AM, Roebrock K, Christensen E, Häberle J. Highly variable clinical phenotype of carbamylphosphate synthetase 1 deficiency in one family: an effect of allelic variation in gene expression?

Deficiency of the urea cycle enzyme carbamylphosphate synthetase 1 (CPS1) causes hyperammonemia with a vast range of clinical severity from neonatal onset with early lethality to onset after age 40 with rare episodes of hyperammonemic confusion. The cause for this variability is not understood. We report two patients from one family with highly divergent clinical course, one presenting neonatally with a fatal form and the other at age 45 with benign diet-responsive disease. The patients are compound heterozygous for two mutations of the CPS1 gene, c.3558 + 1G > C and c.4101 + 2T > C. The haplotypes containing each mutation are identical between the two patients, as are the sequences of CPS1 exons and flanking introns. Transcriptional experiments show that the abnormal CPS1 transcripts generated by both mutations are identical in these two patients. We characterize promoter and enhancer sequences of the CPS1 gene and find also in these regions no sequence differences between patients. Finally, we perform cloning experiments and find that in the neonatal-onset case, clones of messenger RNA (mRNA) expressed from the allele carrying the c.4101 + 2T > C mutation are threefold more than clones of mRNA from the allele with the c.3558 + 1G > C mutation, whereas in the adult-onset case the two types of clones are equal, indicating skewed expression towards the c.4101 + 2T > C allele in the neonatal case. Although we are yet to understand the mechanism of this differential expression, our work suggests that allelic imbalance may explain clinical variability in CPS1 deficiency in some families.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: allelic expression; allelic variation; carbamylphosphate synthetase 1 CPS1; inborn error of metabolism; late-onset urea cycle disorder; neonatal hyperammonemia; regulatory element

Document Type: Research Article

Affiliations: 1: Universitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert- Schweitzer-Str. 33, 48129 Münster, Germany 2: Program in Genetics and Genome Biology and the Division of Neurology, The Hospital for Sick Children, 555 University Ave, Toronto ON, M5G 1X8, Canada 3: Department of Clinical Genetics, Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark 4: Universitätsklinikum Münster, Institut für Immunologie, Röntgenstraße 21, 48149 Münster, Germany

Publication date: September 1, 2009

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more